Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 2.135 USD 1.18%
Market Cap: 78.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

INO Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast INO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INO is 8.16 USD with a low forecast of 2.02 USD and a high forecast of 13.65 USD.

INO Lowest Forecast
Wall Street Target
2.02 USD
5% Downside
INO Average Forecast
Wall Street Target
8.16 USD
282% Upside
INO Highest Forecast
Wall Street Target
13.65 USD
539% Upside
Lowest
Price Target
2.02 USD
5% Downside
Average
Price Target
8.16 USD
282% Upside
Highest
Price Target
13.65 USD
539% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
31% Upside
IONS
Ionis Pharmaceuticals Inc
46% Upside
BVXP
Bioventix PLC
69% Upside
VTVT
vTv Therapeutics Inc
150% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
31% Upside
IONS
Ionis Pharmaceuticals Inc
46% Upside
BVXP
Bioventix PLC
69% Upside
VTVT
vTv Therapeutics Inc
150% Upside
EXEL
Exelixis Inc
4% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
11% Downside
4974
Takara Bio Inc
59% Upside
RCKT
Rocket Pharmaceuticals Inc
423% Upside

Revenue
Forecast

Revenue Estimate
Inovio Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -47%. The projected CAGR for the next 3 years is 598%.

-47%
Past Growth
598%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Inovio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Inovio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
What are analyst estimates?

See Also

Summary
INO intrinsic value, competitors valuation, and company profile.
DCF Valuation
INO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INO stock valuation using valuation multiples.
Wall Street Estimates
INO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INO's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for INO is 8.16 USD with a low forecast of 2.02 USD and a high forecast of 13.65 USD.

What is Inovio Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
598%

For the last 8 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -47%. The projected CAGR for the next 3 years is 598%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.